Advances in genetic research promise great strides in the diagnosis and tre
atment of many childhood diseases. However, emerging genetic technology oft
en enables testing and screening before the development of definitive treat
ment or preventive measures. In these circumstances, careful consideration
must be given to testing and screening of children to ensure that use of th
is technology promotes the best interest of the child. This statement revie
ws considerations for the use of genetic technology for newborn screening,
carrier testing, and testing for susceptibility to late-onset conditions. R
ecommendations are made promoting informed participation by parents for new
born screening and limited use of carrier testing and testing for late-onse
t conditions in the pediatric population. Additional research and education
in this developing area of medicine are encouraged.